R Singla
Overview
Explore the profile of R Singla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
571
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Singh K, Carvalho A, Centis R, D Ambrosio L, Migliori G, Mpagama S, et al.
Int J Tuberc Lung Dis
. 2023 Jun;
27(7):506-519.
PMID: 37353868
Adverse effects (AE) to TB treatment cause morbidity, mortality and treatment interruption. The aim of these clinical standards is to encourage best practise for the diagnosis and management of AE....
2.
Campbell J, Chan E, Anderson L, Bonnet M, Brode S, Cegielski J, et al.
Int J Tuberc Lung Dis
. 2023 Apr;
27(4):338-340.
PMID: 37035974
No abstract available.
3.
Akkerman O, Duarte R, Tiberi S, Schaaf H, Lange C, Alffenaar J, et al.
Int J Tuberc Lung Dis
. 2022 Jun;
26(7):592-604.
PMID: 35768923
The aim of these clinical standards is to provide guidance on 'best practice´ for diagnosis, treatment and management of drug-susceptible pulmonary TB (PTB). A panel of 54 global experts in...
4.
Alffenaar J, Stocker S, Davies Forsman L, Garcia-Prats A, Heysell S, Aarnoutse R, et al.
Int J Tuberc Lung Dis
. 2022 Jun;
26(6):483-499.
PMID: 35650702
Optimal drug dosing is important to ensure adequate response to treatment, prevent development of drug resistance and reduce drug toxicity. The aim of these clinical standards is to provide guidance...
5.
Joshi R, Singla R, Mishra A, Kumar M, Singh R, Singh A, et al.
New Microbes New Infect
. 2022 Jan;
45:100949.
PMID: 35018221
The COVID-19 disease caused by severe acute respiratory syndrome coronavirus -2 (SARS-CoV-2) has posed as a major health concern for people all across the globe. Along with the increasing confirmed...
6.
Migliori G, Marx F, Ambrosino N, Zampogna E, Schaaf H, van der Zalm M, et al.
Int J Tuberc Lung Dis
. 2021 Oct;
25(10):797-813.
PMID: 34615577
Increasing evidence suggests that post-TB lung disease (PTLD) causes significant morbidity and mortality. The aim of these clinical standards is to provide guidance on the assessment and management of PTLD...
7.
Singla R, Singhal R, Rathore R, Gupta A, Sethi P, Myneedu V, et al.
Int J Tuberc Lung Dis
. 2021 Mar;
25(4):324-326.
PMID: 33762078
No abstract available.
8.
Casco N, Jorge A, Palmero D, Alffenaar J, Fox G, Ezz W, et al.
Int J Tuberc Lung Dis
. 2021 Jan;
25(1):78-80.
PMID: 33384052
No abstract available.
9.
Sachdeva K, Arora N, Solanki R, Singla R, Sarin R, Bhatnagar A, et al.
Int J Tuberc Lung Dis
. 2020 Oct;
24(10):1067-1072.
PMID: 33126941
Addressing TB in India is critical to meeting global targets. With the scale-up of diagnostic networks and the availability of new TB drugs, India had the opportunity to improve the...
10.
Sharma A, Batra G, Kumar M, Mishra A, Singla R, Singh A, et al.
Allergol Immunopathol (Madr)
. 2020 Jul;
48(5):507-517.
PMID: 32653224
The impact of COVID-19 is changing with country wise and depend on universal immunization policies. COVID-19 badly affects countries that did not have universal immunization policies or having them only...